The Importance of Mechanisms in the Relationship Between Low Cholesterol and Liver Health
-
By
-
Bertrand Cariou
-
September 10, 2026
Clinical Scorecard: The Importance of Mechanisms in the Relationship Between Low Cholesterol and Liver Health
At a Glance
Category | Detail |
|---|---|
Condition | Low Cholesterol and Liver Health |
Key Mechanisms | Inhibition of PCSK9 and its effects on LDL-C and liver health. |
Target Population | Individuals with genetic PCSK9 loss-of-function variants and primary familial hypobetalipoproteinemia. |
Care Setting | Clinical research and lipid-lowering therapy management. |
Key Highlights
PCSK9 inhibition lowers LDL-C and reduces cardiovascular risk.
Long-term studies show no increased liver disease risk with genetic PCSK9 inhibition.
Primary familial hypobetalipoproteinemia is associated with higher liver complication risks.
Mechanisms of LDL-C reduction influence hepatic outcomes.
Therapeutic strategies must balance LDL-C reduction with hepatic safety.
Guideline-Based Recommendations
Diagnosis
Identify genetic variants associated with PCSK9 loss-of-function.
Management
Consider the underlying mechanism of LDL-C reduction when prescribing therapies.
Monitoring & Follow-up
Regular hepatological surveillance for patients with primary familial hypobetalipoproteinemia.
Risks
Monitor for hepatic steatosis and fibrosis in patients receiving therapies affecting VLDL secretion.
Patient & Prescribing Data
Individuals with low LDL-C due to genetic factors or therapeutic interventions.
Therapies should aim to reduce LDL-C while maintaining hepatic lipid homeostasis.
Clinical Best Practices
Utilize PCSK9 inhibitors and statins for LDL-C reduction while monitoring liver health.
Avoid therapies that promote hepatic triglyceride accumulation.
Related Resources & Content
Di Costanzo et al, UK Biobank, 2023 -- The Importance of Mechanisms in the Relationship Between Low Cholesterol and Liver Health
Clinical Research in Cardiology — Reevaluating the Clinical Importance of HDL Cholesterol
Frontiers in Cardiovascular Medicine — Lysophosphatidylcholine and lysophosphatidic acid as key messengers in atherosclerosis: from a lipid-inflammation vicious cycle to therapeutic translation
The New Gastroenterologist — The Impact of Statins on Liver Health: Safe and Potentially Advantageous
Frontiers in Endocrinology — Interactions Between Lipid Metabolism and MAFLD: Mechanisms and Treatment Approaches
2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia
The Impact of Statins on Liver Health: Safe and Potentially Advantageous
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
PCSK9 in metabolism and diseases - ScienceDirect
Based on findings from:
Low Cholesterol and Liver Risk—The Mechanism Matters
Bertrand Cariou. Jama Network Open, 2026.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2853891
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
